Skip to content

Xencor XNCR Return on equity

Return on equity at other companies

Amgen logo
AmgenAMGN
101.3%-4.4pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
14.5%-1.4pp
Janux Therapeutics logo
Janux TherapeuticsJANX
-11.7%+4.1pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-14.7%-0.8pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-343.8%-1,012pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-37.5%+8.7pp

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Calculated from Xencor’s reported figures.

Based on trailing twelve months.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's return on equity?
Xencor (XNCR) reported return on equity of -29.8% in Q1 2026.
How has Xencor's return on equity changed year-over-year?
Xencor's return on equity increased by 10.0% year-over-year, from -33.2% to -29.8%.
What is the long-term trend for Xencor's return on equity?
Over 5 years (2020 to 2025), Xencor's return on equity has grown at a 3.3% compound annual growth rate (CAGR), from -11.9% to -14%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.